高尿酸血症与代谢综合征及其组分的相关性

目的 分析高尿酸血症与代谢综合征及其组分的相关性。方法 选择2014年新疆医科大学第一附属医院体检中心符合入选标准的2 778名体检者,根据高尿酸血症的诊断标准分为高尿酸血症组（593例)及正常尿酸组(2 185例),对收集的临床及生化指标进行统计分析。结果 高尿酸血症相关因素的单因素分析显示,性别、体质量指数（BMI）、收缩压（SBP）、舒张压（DBP）、三酰甘油（TG）、高密度脂蛋白胆固醇（HDL-C）、空腹血糖（FPG）及是否并发代谢综合征（MS）在高尿酸血症组与正常尿酸组间分布差异有统计学意义（P<0.01）;经多因素Logistic回归分析,BMI（超重/肥胖）、高血压病（SBP、DBP）、高TG、低HDL-C及MS是高尿酸血症发生的相关因素（P<0.01）;Pearson相关性分析示高尿酸血症与HDL-C呈负相关（r=-0.195,P<0.001）。结论 高尿酸血症与代谢综合征组分密切相关。     

高尿酸血症与代谢综合征各组分的相关性研究

通过整群抽样,对中国北方獐子岛地区进行调查与体检,分析高尿酸血症与MS各组分的相关性及患病情况。结果高尿酸血症患者肥胖发生率为63.83%（OR=2.31,95%CI：1.46-3.68）;高血压的发生率为31.52%（OR=3.07,95%CI：1.84-5.09）;高甘油三脂血症发生率为31.52%（OR=2.74,95%CI：1.72-4.36）。对MS的患病风险的OR值分析显示了随年龄的增长而上升的增龄性。以CDS标准分析,40-59岁组MS的患病风险是〈40岁组的13.27倍,而≥60岁组的患病风险是〈40岁组的21.07倍。结论高尿酸血症与MS各组分关系密切,獐子岛地区属沿海岛屿,常年食用大量富含嘌呤的海产品,本研究结果提示该地区高尿酸血症及MS含征的患病率均较高。     

高尿酸血症与代谢综合征

过去一直认为高尿酸血症对人体的影响主要是尿酸盐结晶沉积在关节及肾脏而引起相应的病变。近期许多研究表明 ,高尿酸血症与代谢综合征的许多成分如肥胖、高血压、血脂异常、高血糖症、冠心病及胰岛素抵抗等密切相关。并已成为代谢综合征的一部分 ,二者关系正引起人们的重视。本文将高尿酸血症与代谢综合征的关系作一综述 ,以评价高尿酸血症在代谢综合征中的作用。     

新疆维吾尔族男性高尿酸血症与代谢综合征相关性研究

目的 了解新疆维吾尔族男性高尿酸血症与代谢综合征的相关性.方法 对791例维吾尔族男性体检者的体重、身高、腰围、臀围、舒张压（DBP）、收缩压（SBP）进行测量,并检测相关血液生化指标,包括血尿酸（SUA）、空腹血糖（FBG）、三酰甘油（TG）、总胆固醇（TC）、低密度脂蛋白-胆固醇（LDL-C）、高密度脂蛋白-胆固醇（HDL-C）.结果 此次研究人群中代谢综合征的检出率为18.33％,高尿酸血症检出率为39.95％.高尿酸组患者体质指数（BMI）、腰臀比（WHR）、DBP、SBP、FBG、TC、TG、LDL-C与代谢综合征组的相关指标均高于尿酸正常组,并与血尿酸水平密切相关：高尿酸组与尿酸正常组比较,腹部脂肪堆积、肥胖、高血糖、高三酰甘油血症、高血压的检出率比较差异有统计学意义（P＜0.05）.高尿酸组出现腹部脂肪堆积、肥胖、高血糖、高三酰甘油血症、高血压的风险分别为尿酸正常组的2.126、3.002、2.413、2.903和2.101倍（P＜0.05）.结论 腹部脂肪堆积、肥胖、高血糖、高三酰甘油血症、高血压等代谢综合征相关危险因子是新疆维吾尔族男性发生高尿酸血症的危险因素,应加强对高尿酸血症及代谢综合症患者的健康教育.     

高尿酸血症与代谢综合征的相关性研究

目的：探讨高尿酸血症（HUA）与代谢综合征（MS）的关系。方法随机选取住院的经临床确诊 HUA的75例患者为 HUA组,随机选取同期健康体检的81例非 HUA患者为非 HUA 组,测量人体学指标,检测空腹血糖、甘油三酯、总胆固醇、尿酸,彩色多普勒肝脏检查,采用SPSS 13．0软件分析 HUA 与 MS组分的相关性。结果 HUA 组体质量指数、腰臀比、血清甘油三酯、总胆固醇显著高于非 HUA 组（P＜0．05）。超重（一级肥胖、二级肥胖）、中心型肥胖、高TG血症、高TC血症、脂肪肝是 HUA的相关危险因素（P＜0．05）。两组间二级肥胖和脂肪肝优势比值最高,说明二级肥胖和脂肪肝患者患 HUA的危险性最高。结论 HUA与 MS组分密切相关。     

老年人高尿酸血症特点及与代谢综合征的相关性

<正>随着人们生活水平的提高,高尿酸血症在临床上十分常见〔1〕。代谢综合征是脂质代谢异常、糖代谢异常等各种人体代谢成分异常的综合征。流行病学研究显示,我国成年人代谢综合征的发生率约15%〔2〕;同时,高尿酸血症和代谢综合征的关系密切,且高尿酸血症是心血管事件的独立危险因素〔3〕。因此,研究老年高尿酸血症和代谢综合征的相关性对减少老年心血管事件的发生率有积极的意义。     

武汉地区人群高尿酸血症与代谢综合征的相关性

目的探讨高尿酸血症与代谢综合征的关系。方法对1278名健康体检者进行高尿酸血症与代谢综合征各项指标患病率统计，缸尿酸（SUA）与代谢综合征各项指标的相关分析，SUA与HOMA-IR的多元回归分析。结果（1）高尿酸血症组中肥胖、高腰臀比、IFG、高TC、高TG、高血压病的发生率均比正常尿酸组显著增多（P〈0．05）；（2）SUA与HOMA—IR呈正相关；（3）代谢综合征组高尿酸血症患病率为2z．76％，显著高于正常人群组的患病率11．34％（P〈0．001）。结论高尿酸血症可能是代谢综合征发生发展的重要因素。     

高尿酸血症及痛风与代谢综合征

原发性高尿酸血症（Hyperuricemia）及痛风（Gout）属于代谢性疾病。近年来许多研究表明,高尿酸血症及痛风作为动脉粥样硬化及冠心病的独立危险因子,与代谢综合征的许多成分密切相关,目前,倾向将原发性高尿酸血症纳入代谢综合征范畴,现将它们之间的相关性及可能的机制作一介绍。     

高校老年知识分子高尿酸血症与伴发代谢综合征的相关性

目的 了解高校老年知识分子(≥60岁)高尿酸血症(Hum)的患病情况及其临床特点,并分析与伴发代谢综合征的相关因素.方法 以我市8所大学老年知识分子为研究对象,通过收集和整理686名常规健康体检资料,进行不同年龄段、性别患Hum及伴发代谢综合征的相关性分析.结果 该人群Hum总体患病率为15.45%,男性明显高于女性(P＜0.05),男性各年龄段的发病均高于女性.血尿酸增高患者的高胆固醇、高甘油三酯、高血糖和高血压、脂肪肝、肥胖(超重)、冠心病、痛风、肾功能不全的检出率均明显高于尿酸正常组.结论 Hum是老年人的高发病,且老年Hum与多种心血管或代谢性疾病关系密切,应引起高度重视,因此对该人群积极开展健康保健工作十分重要.     

高尿酸血症、代谢综合征与冠心病的研究进展

正近年来心血管疾病的发病率和病死率呈显著上升趋势。研究表明多种代谢因素与冠心病的发生发展相关,包括代谢综合征、高尿酸血症(hyperuricemia,HUA)、高脂血症等。其中,HUA作为心血管疾病的危险因素已逐渐受到人们的重视,大量研究表明,HUA与高血压、高脂血症等冠心病危险因素相关。同时,是否将HUA纳入到代谢综合征之中,两者对于冠心病的发生发展是否有叠加作用也存在争议。本文旨在探讨HUA对于冠心病的临床影响,并进一步探讨代谢     

高尿酸血症患病率与代谢综合征组分数的关系

浙江宁波某石油化工企业的11016名年龄20-80岁职工的高尿酸血症患病率为12.5％，男性为16．1％，女性为1．9％。与正常血尿酸组比较，高血尿酸组的BMI、BP、FPG和血脂谱均升高（P均〈0．05）。随着代谢综合征组分数的增加，高尿酸血症患病率增加。高尿酸血症独立相关于超重、高血压和血脂异常。     

Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome

Background and aimsThe prevalence of hyperuricemia has increased substantially in recent decades. It has been suggested that it is an independent risk factor for weight gain, hypertension, hypertriglyceridemia, metabolic syndrome (MetS), and cardiovascular disease. Results from epidemiological studies conducted in different study populations have suggested that high consumption of dairy products is associated with a lower risk of developing hyperuricemia. However, this association is still unclear. The aim of the present study is to explore the association of the consumption of total dairy products and their subtypes with the risk of hyperuricemia in an elderly Mediterranean population with MetS.Methods and resultsBaseline cross-sectional analyses were conducted on 6329 men/women (mean age 65 years) with overweight/obesity and MetS from the PREDIMED-Plus cohort. Dairy consumption was assessed using a food frequency questionnaire. Multivariable-adjusted Cox regressions were fitted to analyze the association of quartiles of consumption of total dairy products and their subtypes with the prevalence of hyperuricemia. Participants in the upper quartile of the consumption of total dairy products (multiadjusted prevalence ratio (PR) = 0.84; 95% CI: 0.75–0.94; P-trend 0.02), low-fat dairy products (PR = 0.79; 95% CI: 0.70–0.89; P-trend <0.001), total milk (PR = 0.81; 95% CI: 0.73–0.90; P-trend<0.001), low-fat milk (PR = 0.80; 95% CI: 0.72–0.89; P-trend<0.001, respectively), low-fat yogurt (PR = 0.89; 95% CI: 0.80–0.98; P-trend 0.051), and cheese (PR = 0.86; 95% CI: 0.77–0.96; P-trend 0.003) presented a lower prevalence of hyperuricemia. Whole-fat dairy, fermented dairy, and yogurt consumption were not associated with hyperuricemia.ConclusionsHigh consumption of total dairy products, total milk, low-fat dairy products, low-fat milk, low-fat yogurt, and cheese is associated with a lower risk of hyperuricemia.     

Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan

Insulin resistance is a common feature of metabolic syndrome. Smokers are at great risk of developing insulin resistance. Theoretically, smoking status should be associated with metabolic syndrome. This study aimed to explore the association among cigarette smoking, metabolic syndrome, and its individual components. Information of participants regarding previous and current diseases, family history of disease, smoking habits, alcohol consumption, betel nut chewing, and physical activity status were gathered from self-reported nutrition and lifestyle questionnaires. The fasting plasma glucose, triglyceride level, high-density lipoprotein cholesterol (HDL-C) level, blood pressure, and anthropometric indices in each patient were measured. Data of 1146 male subjects were analyzed. Individuals who currently smoked had a higher prevalence of metabolic syndrome than those who had never smoked and those who had quit smoking. The adjusted odds ratios of current smoking amount showed a statistically significant dose-dependent association with metabolic syndrome, high triglyceride level, and low HDL-C level. Current smokers who smoke > or =20 pack-years have a significantly increased risk of developing metabolic syndrome, high triglyceride level, and low HDL-C level. The higher risk of development of metabolic syndrome, high triglyceride level, and low HDL-C level was insignificant in former smokers. In conclusion, this community-based study supports the view that smoking is associated with metabolic syndrome and its individual components. Smoking cessation is beneficial to metabolic syndrome and its individual components.     

Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults

Metabolic syndrome was associated with the presence and quantity of coronary artery calcium, a marker of subclinical coronary atherosclerosis, in 1,129 asymptomatic adults, ages 20 to 79 years, from a community-based study. The association was independent of 10-year risk of coronary heart disease based on the Framingham risk score.     

Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis

IntroductionCardiovascular disease is an increasingly recognized contributor to excess morbidity and mortality in psoriatic arthritis (PsA). Traditional cardiovascular risk factors do not adequately account for the extent of cardiovascular disease in PsA.Aim of the workTo examine the prevalence of subclinical atherosclerosis in patients with PsA to emphasize the potential role of serum uric acid on endothelial dysfunction, as an early predictor for atherosclerosis in PsA patients.Patients and methodsThis study included 60 PsA patients as well as 60 age and sex matched healthy controls. Assay of serum uric acid, interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1 (sICAM-1) was done for all patients and controls. Patients were subjected to psoriasis area severity index (PASI) and assessment of disease activity. Patients and controls underwent brachial flow-mediated dilatation (FMD) assessment by color duplex sonography to determine endothelial dysfunction as well as extracranial carotid arteries assessment by high-resolution B-mode ultrasound to measure the common carotid intima-media thickness (CIMT) and the detection of atheromatous plaques.ResultsPsA patients have a high significant difference in CIMT, FMD of the brachial artery and mean levels of serum uric acid compared to healthy controls (p < 0.001). PsA patients with hyperuricemia have a high significant difference in CIMT and FMD of the brachial artery than those with normal serum uric acid. Serum uric acid levels showed a high significant positive correlation with each of CIMT, disease duration, markers of inflammation (ESR, CRP, IL-6, sICAM-1), disease activity score in 28 joints (DAS 28) and PASI (r = 0.71, 0.893, 0.956, 0.858, 0.853, 0.877, 0.907, 0.847, respectively, as p < 0.001). A high significant negative correlation was found between serum uric acid levels and FMD of the brachial artery as r = ?0.634, p < 0.001.ConclusionPatients with PsA have a high prevalence of subclinical atherosclerosis dependent on serum uric acid, suggesting that chronic systemic inflammation and endothelial dysfunction appear to be the link between asymptomatic hyperuricemia and atherosclerosis. Therefore, proper control of serum uric acid may play a preventive role in the development of atherosclerosis in PsA patients.     

Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome

Introduction and objectives

A large proportion of patients with coronary disease have metabolic syndrome, although the frequency and association of its different components are not well understood. The aim of this study was to determine the prevalence of metabolic syndrome and the combination of its components in a Spanish cohort of patients with acute coronary syndrome.

Methods

Clinical histories of 574 inpatients with acute coronary syndrome in 6 tertiary hospitals were reviewed and the presence of metabolic syndrome and its components determined by applying Adult Treatment Panel III criteria. In a second step, the components of the metabolic syndrome were analyzed, excluding those patients with diabetes mellitus.

Results

The metabolic syndrome was present in 50.9% of patients and was more frequent in women than in men (66.3% vs. 47.3%; P<.001). The most prevalent component was carbohydrate metabolism disorder (85.3%), followed by low high-density lipoprotein cholesterol (HDLc) levels (80.5%). In nondiabetic patients, 34.6% had metabolic syndrome and the most prevalent component was low HDLc levels (86%), followed by high blood pressure and hypertriglyceridemia and, in fourth place, impaired fasting serum glucose levels.

Conclusions

The metabolic syndrome has a high prevalence in patients with an acute coronary syndrome, especially in women. The most frequent components are hyperglycemia and low HDLc levels. After excluding diabetic patients, the most prevalent diagnostic criterion of metabolic syndrome was low HDLc levels.Full English text available from: www.revespcardiol.org